Trial Profile
A randomized phase 3 trial comparing ALIMTA [pemetrexed] plus best supportive care versus best supportive care alone in previously treated patients with locally advanced or metastatic malignant pleural mesothelioma
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 21 Sep 2007
Price :
$35
*
At a glance
- Drugs Pemetrexed (Primary)
- Indications Malignant-mesothelioma
- Focus Therapeutic Use
- 10 Nov 2005 New trial record.